12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga·03/31/2026 17:05:45
Listen to the news
Gainers
Apellis Pharmaceuticals (NASDAQ:APLS) shares increased by 135.5% to $40.26 during Tuesday's regular session. The company's market cap stands at $2.1 billion.
Bullfrog AI Hldgs (NASDAQ:BFRG) stock moved upwards by 62.85% to $1.71. The company's market cap stands at $13.2 million.
Centessa Pharmaceuticals (NASDAQ:CNTA) stock rose 44.76% to $39.92. The company's market cap stands at $4.0 billion.
Virax Biolabs Group (NASDAQ:VRAX) stock increased by 29.84% to $0.21. The company's market cap stands at $1.2 million.
Cypherpunk Technologies (NASDAQ:CYPH) shares moved upwards by 25.35% to $0.78. The company's market cap stands at $56.2 million.
Insight Molecular (NASDAQ:IMDX) shares rose 24.7% to $3.18. The company's market cap stands at $82.0 million. As per the press release, Q4 earnings came out 3 days ago.
Losers
IO Biotech (NASDAQ:IOBT) stock declined by 73.2% to $0.05 during Tuesday's regular session. The market value of their outstanding shares is at $12.4 million.
PepGen (NASDAQ:PEPG) shares decreased by 63.72% to $1.53. The market value of their outstanding shares is at $290.8 million.
Iterum Therapeutics (NASDAQ:ITRM) stock fell 45.74% to $0.04. The company's market cap stands at $3.7 million.
Phreesia (NYSE:PHR) shares declined by 29.41% to $8.05. The market value of their outstanding shares is at $687.8 million. As per the news, the Q4 earnings report came out yesterday.
Sangamo Therapeutics (NASDAQ:SGMO) stock declined by 25.48% to $0.23. The company's market cap stands at $114.2 million. As per the press release, Q4 earnings came out yesterday.
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure. Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.